PAS
MYGN icon

Point72 Asia (Singapore)’s Myriad Genetics MYGN Stock Holding History

Point72 Asia (Singapore)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$53K Sell
7,324
-6,295
-46% -$37.4K 0.01% 557
2025
Q2 		$72.3K Buy
13,619
+9,604
+239% +$56.7K 0.01% 531
2025
Q1 		$35.6K Buy
+4,015
New +$48.2K 0.01% 623
2024
Q4 		– Sell
-4,833
Closed -$132K – 1099
2024
Q3 		$132K Buy
4,833
+1,471
+44% +$39.8K 0.02% 472
2024
Q2 		$82.2K Buy
+3,362
New +$73.8K 0.02% 536

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asia (Singapore)'s MYGN Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Myriad Genetics (MYGN) stake by 46% in Q3 2025, selling an estimated $37.4K and leaving 7,324 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #557.

Point72 Asia (Singapore) first reported a position in MYGN in Q2 2024 and has held it in 5 quarters since. The position peaked at $132K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Point72 Asia (Singapore) held 7,324 shares of Myriad Genetics worth $53K as of Q3 2025.
  • Point72 Asia (Singapore) sold 6,295 Myriad Genetics shares in Q3 2025, an estimated $37.4K.
  • Myriad Genetics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #557 holding.
  • Point72 Asia (Singapore) first reported a position in Myriad Genetics in Q2 2024 and has held it in 5 quarters since.
  • Point72 Asia (Singapore)'s Myriad Genetics position peaked at $132K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.